Layer-by-layer surface modification of poly(ether sulfone) membranes using polyelectrolytes and AgCl/TiO2 xerogels

In this study, the layer-by-layer (LbL) assembly method was employed to modify a commercial polyethersulfone (PES) membrane by successive adsorption of chitosan and alginate as cationic and anionic polyelectrolytes. To enhance anti-biofouling property, pure, PEG mixed and PEGylated AgCl/TiO2 xerogels were incorporated solely in the top layer of the LbL-modified membranes. Organic and biological foulings were addressed separately using alginate and Escherichia coli bacteria suspensions as the organic and biological model foulants, respectively. LbL-modifying the commercial PES membrane successively with chitosan and alginate polyelectrolyte multilayers prevented organic fouling extensively. In addition, we found that AgCl/TiO2-incorporated membranes show higher water permeability and improved resistance to biological fouling as compared to the PES membrane. Silver amounts in consecutively collected permeate samples were quantified by ICP-MS analysis to assess the stability of AgCl/TiO2-incorporated layers. Silver loss per filtration cycle followed an increasing trend initially, up to a filtration volume totaling 3000L/m2, leading to 4.2% reduction in the immobilized silver amount. After that, silver loss per filtration cycle stabilized at ~7.44μg/L, which extrapolates to ~265 days time-span for the remaining silver to be released at a filtration rate of ~1000L/m2 h. Antibacterial activity tests showed that AgCl/TiO2-incorporated layers do not permit bacterial growth on the membrane surface.European Union (246039

Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery Systems

Chitosan has been the subject of interest for its use as a polymeric drug carrier material in dosage form design due to its appealing properties such as biocompatibility, biodegradability, low toxicity and relatively low production cost from abundant natural sources. However, one drawback of using this natural polysaccharide in modified release dosage forms for oral administration is its fast dissolution rate in the stomach. Since chitosan is positively charged at low pH values (below its pKa value), it spontaneously associates with negatively charged polyions in solution to form polyelectrolyte complexes. These chitosan based polyelectrolyte complexes exhibit favourable physicochemical properties with preservation of chitosan’s biocompatible characteristics. These complexes are therefore good candidate excipient materials for the design of different types of dosage forms. It is the aim of this review to describe complexation of chitosan with selected natural and synthetic polyanions and to indicate some of the factors that influence the formation and stability of these polyelectrolyte complexes. Furthermore, recent investigations into the use of these complexes as excipients in drug delivery systems such as nano- and microparticles, beads, fibers, sponges and matrix type tablets are briefly described

In Vitro Models in Biocompatibility Assessment for Biomedical-Grade Chitosan Derivatives in Wound Management

One of the ultimate goals of wound healing research is to find effective healing techniques that utilize the regeneration of similar tissues. This involves the modification of various wound dressing biomaterials for proper wound management. The biopolymer chitosan (β-1,4-D-glucosamine) has natural biocompatibility and biodegradability that render it suitable for wound management. By definition, a biocompatible biomaterial does not have toxic or injurious effects on biological systems. Chemical and physical modifications of chitosan influence its biocompatibility and biodegradability to an uncertain degree. Hence, the modified biomedical-grade of chitosan derivatives should be pre-examined in vitro in order to produce high-quality, biocompatible dressings. In vitro toxicity examinations are more favorable than those performed in vivo, as the results are more reproducible and predictive. In this paper, basic in vitro tools were used to evaluate cellular and molecular responses with regard to the biocompatibility of biomedical-grade chitosan. Three paramount experimental parameters of biocompatibility in vitro namely cytocompatibility, genotoxicity and skin pro-inflammatory cytokine expression, were generally reviewed for biomedical-grade chitosan as wound dressing

The effect of an autologous cellular gel-matrix integrated implant system on wound healing

<p>Abstract</p> <p>Background</p> <p>This manuscript reports the production and preclinical studies to examine the tolerance and efficacy of an autologous cellular gel-matrix integrated implant system (IIS) aimed to treat full-thickness skin lesions.</p> <p>Methods</p> <p>The best concentration of fibrinogen and thrombin was experimentally determined by employing 28 formula ratios of thrombin and fibrinogen and checking clot formation and apparent stability. IIS was formed by integrating skin cells by means of the <it>in situ </it>gelification of fibrin into a porous crosslinked scaffold composed of chitosan, gelatin and hyaluronic acid. The <it>in vitro </it>cell proliferation within the IIS was examined by the MTT assay and PCNA expression. An experimental rabbit model consisting of six circular lesions was utilized to test each of the components of the IIS. Then, the IIS was utilized in an animal model to cover a 35% body surface full thickness lesion.</p> <p>Results</p> <p>The preclinical assays in rabbits demonstrated that the IIS was well tolerated and also that IIS-treated rabbit with lesions of 35% of their body surface, exhibited a better survival rate (p = 0,06).</p> <p>Conclusion</p> <p>IIS should be further studied as a new wound dressing which shows promising properties, being the most remarkable its good biological tolerance and cell growth promotion properties.</p

SCHISTOSOMA HAEMATOBIUM (TRAITEMENTS ET VACCINS)

LYON1-BU Santé (693882101) / SudocSudocFranceF